Experience of the use of drugs with thioctic acid in overweight women using combined oral contraceptives

Authors

  • N. V. Avramenko Zaporozhye State Medical University,
  • I. B. Gridina Zaporozhye State Medical University,
  • O. A. Nikiforov Zaporozhye State Medical University,
  • E. A. Lomeyko Zaporozhye State Medical University,

DOI:

https://doi.org/10.14739/2310-1210.2014.1.23642

Keywords:

overweight, contraception, thioctic acid

Abstract

Introduction

Overweight is a serious medical, social and economic problem of the modern society. Today it is established that the level of sexual activity in women is not dependent on the body mass index. Unfortunately, about 40% of patients with overweight stop to receive modern combined oral contraceptives in the first two months of the side effects occurrence. Today it is very important to improve the modern combined oral contraceptives intake by women with overweight.

Research objective

To compare tolerance to the modern combined oral contraceptives with thioctic acid in women with excessive body weight.

Materials and methods

64 patients were divided into two groups. Patients of the 1 group (32 observations) were recommended to use thioctic acid in a dose of 600 mg daily for the first month of reception of a modern combined oral contraceptive containing etinilestradiol and desogestrel. Women of the control group (32 observations) used combined oral contraceptives containing levonorgestrel and desogestrel, but not used drugs with thioctic acid.

The results of the research

In the course of the observation spotting were noted in 40% of women in both groups. The nausea was observed in 20% of patients of the second group and only in 7% of the patients in the first group. Decreased libido, and mood were observed only in 5% of patients of the first group and in 15% of patients of the second group. Weight gain within2 kgdue to fluid retention was observed in 30% of patients of the second group and only in 10% of the patients of the first group. After the end of the observation 90% of women of the first group and 75% of women of the second group continued to take combined oral contraceptive.

Conclusions

Use of thioctic acid in a daily dose 600 mg for the first month of intake of the combined oral  contraceptive can significantly reduce the frequency of such unpleasant side effects as nausea, decreased libido, and mood, increased body mass index.

References

Метаболический сердечно-сосудистый синдром / [В.А. Алмазов, Я.В. Благосклонная, Е.В. Шляхто, Е.И. Красильникова]. – СПб.: ГМУ, 1999. – 203 с.

Дедов И.И. Патогенетические аспекты ожирения / И.И. Дедов, Г.А. Мельниченко, Т.И. Романцова // Ожирение и метаболизм. – 2004. – № 1. – С. 3–9.

Критерии приемлемости использования методов контрацепции / Всемирная организация здравоохранения, 2004.

Прилепская В.Н. Гинекологическая эндокринология / В.Н. Прилепская, Е.В. Цаллагова. – М., 2004. – С. 283–320.

Лептин и липидный спектр крови у женщин с разными типами ожирения / А.В. Светлаков, М.В. Яманова, О.С. Филиппов, Н.А. Малахова // Пробл. репродук. – 2001. – №6. – С. 33–35.

Фармацевтична опіка при використанні засобів контрацепції: навчальний посібник / [Ю.П. Вдовиченко, Г.М. Войтенко, І.М. Білай та ін..]. – К.: Книга плюс, 2010. – 176 с.

Huang K.C. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents / Huang KC, Lin RC, Kormas N et al. // International Journal of Obesity. – 2004. – Vol. 12. – P. 23–25.

Roberts L. Obesity. About the size of it / Roberts L., Haycox A. // Health Serv J. – 1999. – Vol. 109 (5662). – Р. 28–29.

Downloads

How to Cite

1.
Avramenko NV, Gridina IB, Nikiforov OA, Lomeyko EA. Experience of the use of drugs with thioctic acid in overweight women using combined oral contraceptives. Zaporozhye Medical Journal [Internet]. 2014Apr.22 [cited 2024Nov.22];16(1). Available from: http://zmj.zsmu.edu.ua/article/view/23642

Issue

No. 1 (2014): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)